Don’t Miss This Trade in uniQure NV (QURE)

A key support level has formed in the chart of uniQure NV (QURE).  A trade below this level could cause a breakdown in the stock…

uniQure NV (QURE) is a gene therapy company. It develops treatment for patients suffering from genetic and other devastating diseases. The company just started clinical trials of a gene therapy for Huntington’s disease. If the gene therapy succeeds, it could mean a $7 billion annual market for QURE.

Take a look at the 1-year chart of QURE with the added notations…

See chart and continue reading at STOCKNEWS.com